Diabetes drug relieves nicotine withdrawal

Diabetes drug relieves nicotine withdrawal
PPARγ transcription levels in the central amygdala. Credit: Domi et al., JNeurosci 2019

A drug commonly used to treat Type II diabetes abolishes the characteristic signs of nicotine withdrawal in rats and mice, according to new research published in JNeurosci. The finding may offer an important new strategy in the battle to quit smoking.

Smokers trying to quit face potent side effects from , including cravings, increased appetite, restlessness, anxiety, irritability, and depression. Even though they may want to quit, many continue to smoke simply because the experience is so unpleasant.

The diabetes drug, pioglitazone, targets a specific form of the peroxisome proliferator-activated receptors in the nucleus. This receptor, PPARγ, is found in areas of the brain involved in .

Domi et al. demonstrated that direct injections of pioglitazone into the hippocampi of male mice reduced the signs of physical nicotine withdrawal, including paw tremors, chattering, and head shakes. Injecting pioglitazone into the amygdala of male mice ameliorated signs of anxiety associated with nicotine withdrawal.

Nicotine abusers face a 30% higher risk of developing Type II diabetes. The researchers suggest pioglitazone may help diabetic smokers quit by lessening the physical and emotional symptoms while reducing insulin resistance.


Explore further

Medicines to help smokers quit only fight half the battle

More information: Activation of PPARγ Attenuates the Expression of Physical and Affective Nicotine Withdrawal Symptoms Through Mechanisms Involving Amygdala and Hippocampus Neurostransmission, JNeurosci (2019). DOI: 10.1523/JNEUROSCI.1922-19.2019
Journal information: Journal of Neuroscience

Citation: Diabetes drug relieves nicotine withdrawal (2019, November 4) retrieved 13 December 2019 from https://medicalxpress.com/news/2019-11-diabetes-drug-relieves-nicotine.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
2 shares

Feedback to editors

User comments